Affordable Care Act, Medicare Part D, Prescription Drugs

Recent Developments in Pharmacy-Related Legislation and Regulations

Wiley Rein LLP on 5/15/2024

Over the last two months, there has been a steady influx of regulatory and legislative efforts regarding drug pricing and the pharmacy industry. To streamline your review, we summarize below a few noteworthy developments that...more

CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B

McDermott Will & Emery on 4/26/2024

On April 15, the Centers for Medicare & Medicaid Services (CMS) released a fact sheet on the potential national coverage determination (NCD) for pre-exposure prophylaxis (PrEP) using antiretroviral drugs to prevent HIV. CMS...more

Holland & Knight Health Dose: March 12, 2024

Holland & Knight LLP on 3/14/2024

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector....more

The Inflation Reduction Act of 2022: Healthcare Provisions

McDermott Will & Emery on 9/9/2022

After almost a year of negotiations among congressional Democrats and the White House, the Inflation Reduction Act of 2022 (IRA) was signed into law by President Biden on August 16, 2022. It passed in the US Senate by a vote...more

Benefits-Related Provisions of the Inflation Reduction Act of 2022

Groom Law Group, Chartered on 8/31/2022

On August 16, President Biden signed into law the Inflation Reduction Act of 2022 (P.L. 117-169; the “Act”). Although the Act differs considerably from the wide-ranging domestic economic package Democrats had initially...more

With Inflation Reduction Act Signed, Other Health Policy Issues Ahead for Congress

Holland & Knight LLP on 8/17/2022

Congress ended a busy work period after passing the Inflation Reduction Act (IRA) last week. This Holland & Knight alert summarizes the healthcare provisions in the IRA and provides an outlook on health policy issues that may...more

The Inflation Reduction Act: Summary of the Budget Reconciliation Act

Holland & Knight LLP on 8/8/2022

The U.S. Senate on Aug. 7, 2022, passed the Inflation Reduction Act of 2022 (IRA). This comprehensive legislation is the result of many months of negotiations among Democrats to advance some of President Joe Biden's highest...more

House Passes Build Back Better Act

Groom Law Group, Chartered on 11/24/2021

On November 19, 2021, the U.S. House of Representatives voted to approve the Build Back Better Act (H.R. 5376, the “BBB Act”), the budget reconciliation bill that includes much of President Biden’s economic and social policy...more

Senate Lays Groundwork for Fall Health Care Negotiations Before Recessing This Month

Manatt, Phelps & Phillips, LLP on 8/17/2021

The Big Picture - Before leaving for its August recess, the Senate made progress on two major Biden Administration priorities by passing bipartisan infrastructure legislation and a fiscal year (FY) 2022 budget resolution....more

The American Families Plan & A Call for Drug Pricing Legislation

Mintz - Health Care Viewpoints on 5/11/2021

On April 28, 2021, President Biden gave his first address to Congress and announced the American Families Plan (AFP or the Act). The AFP follows the 1.9 trillion-dollar stimulus, the American Rescue Plan Act, signed into law...more

After the Election: Policy Priorities for Health Care Programs

Faegre Drinker Biddle & Reath LLP on 11/24/2020

Health care policy has been a key issue leading up to the 2020 elections, and the final outcome of the presidential and congressional elections will likely impact the health care policy priorities of the future. While the...more

Washington Healthcare Update - March 2020 #4

McGuireWoods Consulting on 3/24/2020

This week in Washington: Congress debates additional legislation to address the coronavirus (COVID-19) pandemic. ...more

Benefits Odds and Ends to Start the Fall

Nelson Mullins Riley & Scarborough LLP on 9/12/2019

With the passing of summer and the children back in school, it is time to get to work and check on benefit compliance items that you may have missed over the summer. Below is a short summary of a number of developments....more

ML Strategies Health Care Preview - May 2019 #2

Mintz - Health Care Viewpoints on 5/9/2019

This week, the full House is poised to take its first action on drug pricing, voting on a pair of bills that would improve access to drug patents. The first bill is H.R. 1520, the Purple Book Continuity Act of 2019, which...more

ML Strategies Health Care Preview - May 2019

Mintz - Health Care Viewpoints on 5/8/2019

This week, the full House is poised to take its first action on drug pricing, voting on a pair of bills that would improve access to drug patents. The first bill is H.R. 1520, the Purple Book Continuity Act of 2019, which...more

Capitol Hill Healthcare Update

BakerHostetler on 3/4/2019

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: PBMs next in Senate committee’s crosshairs; lawmakers continue scrutiny on insulin prices;...more

Washington Healthcare Update February 2019 #1

McGuireWoods Consulting on 2/5/2019

Coming Week’s Highlights: State of the Union scheduled for Feb. 5; House committees continue discussion on pre-existing conditions....more

Capitol Hill Healthcare Update

BakerHostetler on 2/5/2019

Below is this week’s “Capitol Hill Healthcare Update,” which is posted on Mondays when Congress is in session. Highlights this week: Trump will discuss healthcare and drug costs in this week’s State of the Union address;...more

Capitol Hill Healthcare Update

BakerHostetler on 1/14/2019

Highlights this week: Nearly 7,000 FDA employees are furloughed amid the ongoing government shutdown; lawmakers introduce a slew of anti-pharma bills; 18 new Democrats land plum spots on key healthcare committees; and more....more

Washington Healthcare Update

McGuireWoods Consulting on 12/4/2018

This Week: Congress focuses on organizing for the next Congress and the continuing resolution; previews of drug pricing legislation for the next Congress; CMS issues controversial guidance concerning how states can use...more

Health Care Policy Newsletter - July 2018 #4

Foley & Lardner LLP on 7/30/2018

Foley & Lardner LLP’s Bipartisan Public Policy Team is pleased to share this week’s “Public Policy Health Care Newsletter” in which we compile the latest health care policy news and legislation. Please note that the next...more

Health Care Policy Newsletter - June 2018

Foley & Lardner LLP on 6/12/2018

Foley’s Bipartisan Public Policy Team is pleased to share our “Public Policy Health Care Newsletter” in which we compile the latest health care policy news and legislation. *Please note that we publish this newsletter only...more

Health Care Policy Newsletter - May 2018 pt 3

Foley & Lardner LLP on 5/29/2018

Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly Health Care Newsletter” in which we compile the latest health care policy news and legislation....more

Trump Administration Fiscal Year (FY) 2019 Budget and Healthcare Programs

Holland & Knight LLP on 2/19/2018

The Trump Administration on Feb. 12 released its Fiscal Year (FY) 2019 budget request, titled "An American Budget." Unlike last year's budget, which was released in late May, the release of this budget conforms to the typical...more

The Future of the Affordable Care Act Week 7: The American Health Care Act

Mintz - Employment Viewpoints on 3/22/2017

On March 6, 2017, after years of promising, GOP lawmakers in the House of Representatives introduced the “American Health Care Act” (AHCA), the first concrete legislative proposal detailing the initial provisions designed to...more

Patient Protection and Affordable Care Act (PPACA) › Medicare Part D › Prescription Drugs

"My best business intelligence, in one easy email…"